Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Long-Term Deferred Tax (2025)

TransMedics (TMDX) has 1 years of Long-Term Deferred Tax data on record, last reported at $83.5 million in Q4 2025.

  • For Q4 2025, Long-Term Deferred Tax changed N/A year-over-year to $83.5 million; the TTM value through Dec 2025 reached $83.5 million, changed N/A, while the annual FY2025 figure was $83.5 million, N/A changed from the prior year.
  • Long-Term Deferred Tax reached $83.5 million in Q4 2025 per TMDX's latest filing.
  • Across five years, Long-Term Deferred Tax topped out at $83.5 million in Q4 2025 and bottomed at $83.5 million in Q4 2025.